Skip to main content
. Author manuscript; available in PMC: 2021 Mar 7.
Published in final edited form as: Genet Med. 2020 Sep 7;23(1):80–85. doi: 10.1038/s41436-020-00956-3

Table 2.

Summary of clinical findings of Carney Complex (CNC) patients with and without cardiac myxoma, based on diagnostic criteria.

CNC patients without cardiac myxoma (n=184, F=103, M=74, uncertain=7) CNC patients with cardiac myxoma (n=136, F=78, M=58) P-value CNC patients with at least 1 recurrence (n=60, F=44, M=16) P-value
Lentigines (%) 59 (32) 88 (64.7) 0.00008 36 (60) 0.3
Blue nevi (%) 14 (7.6) 14 (10.3) 0.1 3 (5) 0.06
Cutaneous myxoma (%) 28 (15.2) 41 (30.1) 0.01 19 (31.6) 0.9
Breast myxomatosis (%) 10 (9.7) 27 (34.6) 0.008 16 (36.3) 0.1
Thyroid manifestationsa (%) 15 (8.1) 35 (25.7) 0.001 20 (33.3) 0.1
LCCSCT or calcifications on testicular U/S (%) 23 (31) 29 (50) 0.3 9 (56.3) 0.09
Pituitary adenoma (%) 15 (8.1) 28 (20.6) 0.004 14 (23.3) 0.1
PMS (%) 4 (2.1) 16 (11.7) 0.009 8 (13.3) 0.5
PPNAD (%) 56 (30.4) 57 (41.9) 0.07 29 (48.3) 0.2

LCCSCT: large cell calcifying sertoli cell tumor; PMS: Psammomatous melanotic schwannoma; PPNAD: primary pigmented nodular adrenocortical disease; u/s: ultrasound; F=female; M=male

Significance was set at <0.05

a

Includes: Thyroid carcinoma or multiple, hypoechoic nodules on thyroid ultrasonography